
|Articles|October 3, 2008
Merz USA names new president and CEO
Greensboro, N.C. - Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to dbusinessnews.com.
Advertisement
Greensboro, N.C.
- Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to
dbusinessnews.com
.
Mr. Britts will oversee the medical dermatology business, as well as establish two new product avenues in aesthetics and neurology.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











